Evidence map›Paper›PMID 36504835›Full record

ArticleFrontiers in microbiology2022

Four new species and three new records of helicosporous hyphomycetes from China and their multi-gene phylogenies.

Yong-Zhong Lu, Jian Ma, Xing-Juan Xiao, Li-Juan Zhang, Yuan-Pin Xiao, Ji-Chuan Kang

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Two newMycoKeys · 2026
    Article
  5. Two novel species ofMycoKeys · 2026
    Article
  6. Two new species ofMycoKeys · 2026
    Article
  7. NovelMycoKeys · 2025
    Article
  8. NovelMycoKeys · 2025
    Article
  9. Two new species ofMycoKeys · 2025
    Article
  10. Article
  11. Article
  12. Two novelMycoKeys · 2025
    Article
  13. Two new species ofMycoKeys · 2025
    Article
  14. NovelMycoKeys · 2024
    Article
  15. Three new species ofMycoKeys · 2024
    Article
  16. Additions to the GenusJournal of fungi (Basel, Switzerland) · 2023
    Article
  17. Morphological and Multi-Gene Phylogenetic Analyses RevealJournal of fungi (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yong-Zhong LuEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang, China.
Jian MaSchool of Pharmaceutical Engineering, Guizhou Institute of Technology, Guiyang, China.
Xing-Juan XiaoSchool of Pharmaceutical Engineering, Guizhou Institute of Technology, Guiyang, China.
Li-Juan ZhangSchool of Pharmaceutical Engineering, Guizhou Institute of Technology, Guiyang, China.
Yuan-Pin XiaoEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang, China.
Ji-Chuan KangEngineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helicosporous hyphomycetes have the potential to produce a variety of bioactive compounds. However, the strain resources of this fungal group are relatively scarce, which limits their further exploitation and utilization. In this study, based on phylogenetic analyses of combined ITS, LSU, RPB2, and TEF1α sequence data and the morphology from 11 isolates, we introduce four new species of helicosporous hyphomycetes,

Indexed as

freshwater fungisaprophytic fungitaxonomyTubeufialeswoody substrates

Identifiers

PMID36504835
PMCPMC9732463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.